Specialties

Diabetes

Information for healthcare professionals

Now shipping:
Instinct sensor

Made by Abbott exclusively for MiniMed systems

The MiniMed™ 780G system anticipates, adjusts, and corrects every 5, minutes even when carb counts aren’t exact,^† and can now be used with the smallest, longest-wear sensor. Help your patients get started today.

Learn more

Important Safety InformationMINIMED™ 780G SYSTEM WITH SMARTGUARD™ TECHNOLOGY WITH INSTINCT SENSORThe MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.The Instinct sensor can be used one time and has a life up to 15 days. The Instinct sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Instinct sensor. The Instinct sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Only apply the sensor to the back of your upper arm. The sensor may not work properly in other areas.The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump and the Instinct sensor. The system requires a prescription from a healthcare professional.WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system..WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

MINIMED™ 780G system

Now approved for adults with insulin-requiring type 2 diabetes

with Simplera Sync™ sensor and Guardian™ 4 sensor

Education and resources

NEW EPISODES MONTHLY

Advancing the Dose: A podcast for healthcare professionals

Tune in as we explore the innovations in diabetes technologies, clinical data, and more.

Advancing the Dose features guest speakers who are key opinion leaders in the diabetes treatment space, case studies, and discussions on how new technologies are shaping diabetes management.

Listen to podcast

Live and on-demand webinars

Resources and downloads

Training references, quick reference guides, and other PDFs

Visit library

Medtronic Academy

An online learning experience for healthcare professionals

Visit Medtronic Academy (open in new window)

Latest news

Big news to share: our next chapter!

Today, we shared some big news! Medtronic announced its intent to separate our Diabetes business into a standalone, public company. This exciting next phase provides a great opportunity to accelerate innovation to further improve glycemic outcomes while reducing the burden of diabetes management.

Get in touch

This form is for healthcare professionals practicing in the United States only.
If you are a patient looking for more information, click here

First name

Last name

Credentials (if any)

NPI number

Practice/Institution name

ZIP code

Phone number

Title/Role

Country/Region

I agree to receive emails from Medtronic Diabetes.

I have read and agree with the terms and conditions.

Products

† Refers to SmartGuard™ feature. Individual results may vary.
‡ Fingersticks required in manual mode & to enter smartguard. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.

1. Data on file, Abbott Diabetes Care, Inc.
2. Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.

©2025 Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image © 2025 Abbott. ™*Third–party brands are trademarks of their respective owners.